On Jul. 30, 2020, INOVIO announced that its COVID-19 DNA vaccine INO-4800 targeting SARS-CoV-2 was effective in protecting…
On Jul. 29, 2020, the Encyclopedia of DNA Elements (ENCODE) Project is a worldwide effort to understand how…
On Jul. 29, 2020, Intravacc and Celonic Group, a biopharmaceutical contract development and manufacturing organization (CDMO), announced that…
On Jul. 29, 2020, PharmaCyte Biotech announced that the COVID-19 Molecular tests it has licensed from Hai Kang…
On Jul. 29, 2020, Veracyte and MAVIDx announced an agreement for MAVIDx to develop ultra-high throughput genomic testing…
On Jul. 29, 2020, Constant Therapeutics announced that its peptide drug TXA127, a pharmaceutical formulation of the natural…
On Jul. 29, 2020, Heat Biologics announced successful pre-clinical testing of the Company’s COVID-19 vaccine, which demonstrated in-vivo…
On Jul. 29, 2020, Quest Diagnostics announced that the FDA had granted emergency use authorization for a new…
On Jul. 29, 2020, Regeneron announced that the Biomedical Advanced Research and Development Authority (BARDA) had entered into…
On Jul. 29, 2020, Sanofi and GSK announced an agreement with the UK government for the supply of…
On Jul. 29, 2020, Roche announced the initiation of a global phase III, randomised, double-blind, multicentre study (REMDACTA)…
On Jul. 28, 2020, the U.S. International Development Finance Corp. (DFC) announced that it had signed a letter…
On Jul. 28, 2020, scientists at the National Institute of Allergy and Infectious Diseases reported that two doses…
On Jul. 28, 2020, Apogenix announced that it had received regulatory approval to start a clinical phase II…
On Jul. 28, 2020, Gilead Sciences and the Satcher Health Leadership Institute at Morehouse School of Medicine announced…
On Jul. 28, 2020, StartX, a non-profit startup community of more than 1600 Stanford faculty and alumni founders,…
On Jul. 28, 2020, Moderna announced a preclinical study evaluating mRNA-1273, its vaccine candidate against COVID-19, was published…
On Jul. 28, 2020, Soligenix announced publication of pre-clinical immunogenicity studies for its CiVax program (heat stable COVID-19…
On Jul. 28, 2020, Reata Pharmaceuticals announced that researchers at NYU Grossman School of Medicine (NYU) initiated an…
On Jul. 28, 2020, Soligenix announced publication of pre-clinical immunogenicity studies for its CiVax™ program (heat stable COVID-19…
On Jul. 27, 2020, the NIH launched a $58 million initiative to advance data science, catalyze innovation and…
On Jul. 27, 2020, a phase 3 clinical trial designed to evaluate if an investigational vaccine can prevent…
On Jul. 27, 2020, the Serum Institute of India announced that it was is conducting phase III clinical…
On Jul. 27, 2020, Amyris and the Infectious Disease Research Institute (IDRI) announced the signing of a binding…
On Jul. 27, 2020, Emergent BioSolutions announced that it had signed an agreement to provide contract development and…
On Jul. 27, 2020, MediciNova announced an agreement with BioComo and Mie University (Mie prefecture, Japan) for joint…
On Jul. 27, 2020, Humanigen announced that the National Institute of Allergy and Infectious Diseases and Humanigen had…
On Jul. 27, 2020, Moderna announced that the Phase 3 study of its mRNA vaccine candidate (mRNA-1273) against…
On Jul. 27, 2020, Todos Medical announced the Company has entered into a contract to supply NJ-based laboratory…
On Jul. 27, 2020, Immunic announced enrollment of the first patients in an investigator-sponsored phase 2 clinical trial…